| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CURRENT TREATMENT OPTIONS IN ONCOLOGY LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 5.1 Speed 7.0 | ||||||||||||||||||||
| 期刊簡稱 | CURR TREAT OPTION ON | ||||||||||||||||||||
| ISSN | 1527-2729 | ||||||||||||||||||||
| E-ISSN | 1534-6277 | ||||||||||||||||||||
| h-index | 48 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | https://www.springer.com/11864 | ||||||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/ctoo | ||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||
| 出版商 | Springer US | ||||||||||||||||||||
| 主題領域 | ONCOLOGY | ||||||||||||||||||||
| 出版國/地區 | US | ||||||||||||||||||||
| 發行頻率 | 隔月刊行 | ||||||||||||||||||||
| 創刊年 | 2000 | ||||||||||||||||||||
| 每年文章數 | 114每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 20.75% | ||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q2
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1527-2729%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [CURRENT TREATMENT OPTIONS IN ONCOLOGY] 的評論 | 撰寫評論 |
| 作者: 落英巧易 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2024-01-27 15:52:07 評論於 Research focus: Oncology; Sharing experience in writing review articles: Why isn't anyone talking about this journal? I have been transferred to this journal by the editor, and it has been 10 days since the Editor appointed. Can anyone who has submitted to this journal share if it is easy to get accepted?  (0) 讚！ | 落英巧易  |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 18:42:21 評論於 Focus on refining your hypothesis or innovative point. The best title should accurately describe the content of the paper with the fewest necessary terms. Writing requires accuracy, brevity, clarity, and attractiveness (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 15:49:17 評論於 Most journals have specific requirements for articles, as well as a checklist that can be used as a reference. Writers can also refer to articles already published in the target journal for guidance (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-27 13:11:06 評論於 Is there a template for writing SCI papers? (0) 讚！ | 陶宜三岁啦 |
| 作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-26 21:01:27 評論於 How to refine/write article titles? (0) 讚！ | 修然小公主 |
| 作者: 震雷统乐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2020-12-27 17:07:24 評論於 How long is the review period? What is the accuracy rate? (0) 讚！ | 震雷统乐 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2017-07-18 09:59:40 評論於 Everything can only hope for next year, after all, as long as the overall is increasing, there is no need to worry. Even if it only rises a little bit in a year, it is still good in the long run (0) 讚！ | 凌霄高洁 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2012-11-28 23:57:07 評論於 Can we reach 3 points next year? Let's discuss (0) 讚！ | 凌霄高洁 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2011-06-29 20:14:16 評論於 Research Focus: Tumor; Cancer (0) 讚！ | 凌霄高洁 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
